Idenix asserts patent infringement against Gilead in Canada related to Sovaldi® and Harvoni®
Clients Idenix Pharmaceuticals LLC
Jones Day represents Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in patent litigation against Gilead in Federal Court in Canada over sofosbuvir, the active ingredient in Sovaldi® and Harvoni®, Gilead's blockbuster drugs for treating Hepatitis C. Subject matter is nucleoside analogs and prodrugs for treating Flaviviridae infections, including HCV.
Gilead Sciences, Inc., et al. v. Idenix Pharmaceuticals, Inc., et al., Court File T-1156-12 (Federal Court of Canada)